Enrolling by invitationNot applicableNCT02483260
Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever
Studying Viral hemorrhagic fever
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- U.S. Army Medical Research and Development Command
- Principal Investigator
- Joshua Hawley-Molloy, MDLandstahl Regional Medical Center
- Intervention
- Ribavirin(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2016 – 2028
Study locations (1)
- Landstuhl Regional Medical Center, Landstuhl, APO AE, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02483260 on ClinicalTrials.gov